winner
- Venus Concept Inc. VERO up 54.9% on Friday to $0.5419. The company released staggering quarterly results last month.
- PaxMedica, Inc. PXMD rose 47.7% to $5.17 on Friday. PaxMedica’s Executive Chairman, Director Michael Derby, reported to Form4 that he had tendered the purchase of 95,000 shares at a price of $5.25 per share.
- Sunrise New Energy Co., Ltd. EPOW gained 31.5% to close at $2.80.
- Wheeler Real Estate Investment Trust, Inc. WHLR rose 26.9% to close at $2.65.
- Rubius Therapeutics, Inc. RUBY gained 23.4% to close at $0.9254. The company posted a lower-than-expected quarterly loss last month.
- Pear Therapeutics, Inc. PEAR rose 21.7% to close at $2.13.
- Bright Minds Biosciences Inc. DRUG rose 21.4% to close at $1.93. Bright Minds Biosciences recently began dosing BMB-101 in a Phase I clinical trial in Dravet Syndrome.
- NewAge, Inc. NBEV Shares rose 21.3% to close at $0.1482 on Friday on continued volatility after the company recently announced it had filed a voluntary filing for relief under Chapter 11 of the US Bankruptcy Code. The stock is recovering after trading lower on Thursday.
- Liquidia Corporation LQDA gained 20.6% to close at $5.86. Needham kept Liquidia on buy, increasing the price target to $16 from $12.
- Reviva Pharmaceuticals Holdings, Inc. RVPH rose 18.8% to close at $2.66.
- Forza X1, Inc. FRZA rose 18.1% to close at $4.39.
- United Maritime Corp USE A rose 17.4% to $1.42 after the company announced a $3 million buyback plan.
- Hollysys Automation Technologies Ltd. HOLI rose 16.5% to close at $19.76. A consortium led by the management of China’s Hollysys Automation plans to privatize the US-listed automation and control systems manufacturer in a deal worth US$1.8 billion, Reuters reported.
- TScan Therapeutics, Inc. TCRX rose 16.4% to close at $3.27. TScan Therapeutics posted a Q2 loss of $0.63 per share last month.
- Rain Therapeutics Inc. RAIN rose 15.8% to…
